Olaparib in Recurrent IDH-mutant Glioma
Clinical trial NCT03561870 · COMPLETED
Trial details
- NCT number
- NCT03561870
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2021-11-08
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.